SpartaLabs
June 17, 2026
CJC-1295 Without DAC: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies CJC-1295 without DAC for research applications. Educational reference.
cjc-1295-without-dacsourcingquality
Peptide
CJC-1295 Without DAC
Tetra-substituted GHRH (1-29) analogue, no DAC. Lyophilized. ≥ 99% purity.
From$65.00
In Stock
Dosage
Quantity
- SKU
- SL-CJCNODAC-5MG
- Category
- Peptide
- Purity
- ≥ 99%
- COA
- Available
CJC-1295 Without DAC (also referred to as Mod GRF 1-29) is a synthetic tetra-substituted analogue of the first 29 amino acids of growth hormone releasing hormone (GHRH), without the Drug Affinity Complex linker.
Compared to the DAC-modified variant, this shorter-acting form is used in preclinical studies of pulsatile GHRH-receptor signalling.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples at 2-8 °C. For laboratory and research use only. Not for human or veterinary use.
Every batch of CJC-1295 Without DAC is independently tested by a third-party laboratory. Certificates of Analysis include HPLC purity testing, mass spectrometry confirmation, and sterility verification.
Contact us at info@spartalabs.net to request the COA for this product.
Orders are processed within 1–2 business days. Standard shipping typically takes 3–5 business days within the continental United States.
All products are shipped in temperature-controlled, discreet packaging to ensure product integrity.
CJC-1295 Without DAC (also referred to as Mod GRF 1-29) is a synthetic tetra-substituted analogue of the first 29 amino acids of growth hormone releasing hormone (GHRH), without the Drug Affinity Complex linker.
Compared to the DAC-modified variant, this shorter-acting form is used in preclinical studies of pulsatile GHRH-receptor signalling.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples at 2-8 °C. For laboratory and research use only. Not for human or veterinary use.
